HIV and TB statistics in Ukraine: June 2020

According to the Center for Public Health of the Ministry of Health of Ukraine, in June 2020, 1,467 new cases of HIV infection and 1,199 cases of tuberculosis were officially registered in Ukraine (excluding data from Crimea from 2014 and parts of Donetsk and Luhansk from 2015). 

HIV infection:

Of the 1,467 new HIV cases reported, 374 patients were diagnosed with AIDS and 183 died of AIDS.

Ways of HIV infection in Ukraine in June 2020:

    • heterosexual - 794;
    • parenteral - 632;
    • homosexual - 37;
    • other non-medical interventions - 1;
    • vertical - 139 (most of them (about 98%) after 18 months will not have HIV);
    • unknown - 2.

Tuberculosis:

In June 2020, 1,199 cases of tuberculosis were registered:

    • 971 new cases;
    • 1 case with an unknown history of previous treatment;
    • 228 patients with relapse;
    • 22 patients who resumed treatment after a break;
    • 82 patients who started re-treatment after failure;
    • 41 another case.

In June 2020, a total of 15,731 people were treated for tuberculosis.

As part of the fight against HIV in the USА, a new ARVT drug Trogarzo (ibalizumab) was approved

As part of therapy, Trogarzo (ibalizumab) will be used by people who have experienced ineffective treatment with other ARVs. The new drug could be a solution for those who have been living with HIV for a long time and whose virus has acquired resistance to most of the available drugs.

A new study found that people with Trogarzo (Ibalizumab) were able to achieve a reduction in viral load 48 weeks before a condition when the virus was not detected by a test.

The new drug has proven to be safe and effective both in the third phase and in human studies. The most common side effects were diarrhea, headache, fatigue and nausea. However, all side effects were mild or moderate. In addition, Trogarzo is the first HIV drug to be taken not every day, but only once every two weeks.

The cause of resistance is incomplete suppression of virus mutations that occur in cases where the patient violates the treatment regimen. Multiple resistance is dangerous because at some stage it becomes difficult or impossible for the patient to find an effective alternative treatment regimen.

A practical guide for healthcare professionals adapted to the conditions of the COVID-19 pandemic has been developed

WHO has developed a practical guide adapted to the conditions of the COVID-19 pandemic for healthcare professionals treating patients with severe acute respiratory viral infections.

The manual provides tools and practical recommendations that can be used to care for patients with severe disease: from admission to discharge from hospital.

The Ukrainian, English and Russian versions of the manual can be downloaded here: Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation 

COVID-19 Lessons on Improving Service Sustainability for Eastern Europe and Central Asia

Following the online discussion “COVID-19 Lessons on Improving Service Sustainability Indicators for Eastern Europe and Central Asia” held in May 2020, practical recommendations for transforming a sustainable response to HIV, TB and HCV in the context of COVID-19 were developed and published. 

Stakeholder experts report the need to:

  • Reformatting health care systems in response to COVID-19;
  • Increasing the availability of diagnosis and treatment;
  • Transformations of HIV, TB and HCV service delivery models for key groups.

The COVID-19 pandemic has shown that health systems around the world need to become more resilient, flexible and result-oriented. The approach to the provision of a range of services has changed, including the treatment of HIV and opioid dependence, as well as TB and hepatitis C virus (HCV) among key populations.

So, we present the main theses of the online conference:

  • Effective communication by the government is very important during a crisis. It is the government that must prepare citizens for the probable development of events and involve the population in measures to counteract the epidemic.
  • In an epidemic, it is crucial to unlock emergency funding in a timely manner. Timely allocation of funds facilitates the use of funds and helps to strike a balance between flexibility and accountability.
  • Global communication and recommendations are an important source of information for national decision-making.
  • The use of information technology (IT) as a means of monitoring and protecting society from COVID-19 has become an important innovation.
  • New global mechanisms need to be sought to prevent supply disruptions at the local level.
  • Possibilities for reviewing patent rights in emergencies should be considered.
  • A reorientation of international assistance programs is needed to support measures to combat COVID-19.
  • Models of service delivery for key groups in relation to HIV, TB and HCV need to transform and simplify methods for the benefit of patients.

The full findings of the online discussion "COVID-19 Lessons on Improving Service Sustainability for Eastern Europe and Central Asia" can be found here.

 

Partners

 

Need to talk to us

Phone: +38 (044) 569 28 52
Fax: +38 (044) 569 28 52
Staronavodnickaya 13A st., office 35.

Email: aids-institute@aids-institute.org

About us

Back to top
ankara otel şarkı sözleri iç mimarlık ankara rent a car ankara seks izle